Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Jan 27, 2021; 13(1): 50-75
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.50
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.50
Table 8 Demographic and patient-related preoperative potential prognostic factors for liver and lung recurrence
Recurrence, n = 58 | ||||||||
Liver | Lung | |||||||
No, n = 33 (55.0%) | Yes, n = 25 (41.7%) | HR (95%CI) | P value | No, n = 42 (70.0%) | Yes, n = 16 (26.7%) | HR (95%CI) | P value | |
Age, yr, mean ± SD | 67.4 ± 12.3 | 68.0 ± 12.3 | 1.00 (0.97-1.03) | 0.945 | 67.3 ± 12.7 | 68.7 ± 11.0 | 1.00 (0.96-1.04) | 0.837 |
Gender, n (%) | 0.702 | 0.185 | ||||||
Male | 16 (55.2) | 13 (44.8) | Reference | 19 (65.5) | 10 (34.5) | Reference | ||
Female | 17 (58.6) | 12 (41.4) | 0.86 (0.39-1.88) | 23 (79.3) | 6 (20.7) | 0.50 (0.18-1.39) | ||
Preop Hb, g/dL, mean ± SD | 11.28 | 11.93 | 1.16 (0.88-1.53) | 0.296 | 11.4 ± 2.3 | 12.0 ± 2.5 | 1.14 (0.81-1.61) | 0.446 |
Preop glycemia, g/dL, mean ± SD | 1.08 ± 0.36 | 1.08 ± 0.31 | 1.72 (0.14-10.00) | 0.884 | 1.06 ± 0.33 | 1.14 ± 0.35 | 1.47 (0.12-18.20) | 0.764 |
Preop total proteins, g/dL, mean ± SD | 6.7 ± 0.7 | 7.1 ± 0.8 | 1.33 (0.56-3.17) | 0.514 | 6.9 ± 0.9 | 6.9 ± 0.5 | 0.87 (0.19-3.93) | 0.861 |
Preop CEA, n (%) | 0.868 | 0.891 | ||||||
< 5 ng/mL | 6 (46.2) | 7 (53.8) | Reference | 10 (76.9) | 3 (23.1) | Reference | ||
≥ 5 ng/mL | 4 (57.1) | 3 (42.9) | 0.89 (0.23-3.46) | 5 (71.4) | 2 (28.6) | 1.14 (0.18-7.14) | ||
Missing | 23 | 15 | 27 | 11 | ||||
BMI, mean ± SD | 26.3 ± 4.9 | 27.8 ± 4.7 | 1.04 (0.94-1.15) | 0.465 | 27.6 ± 4.8 | 25.7 ± 4.6 | 0.96 (0.83-1.13) | 0.646 |
ASA, n (%) | ||||||||
1 | 3 (60) | 2 (40) | Reference | 4 (80) | 1 (20) | Reference | ||
2 | 8 (42.1) | 11 (57.9) | 0.64 (0.15-2.75) | 0.544 | 14 (73.7) | 5 (26.3) | 0.46 (0.06-3.38) | 0.447 |
3 | 13 (61.9) | 8 (38.1) | 0.34 (0.07-1.55) | 0.163 | 15 (71.4) | 6 (28.6) | 0.31 (0.04-2.35) | 0.258 |
4 | 3 (100) | 0 (0.0) | 0.30 (0.01-7.69) | 0.471 | 2 (66.7) | 1 (33.3) | 2.09 (0.16-27.56) | 0.573 |
Missing | 6 | 4 | 7 | 3 | ||||
Presentation with occlusion, n (%) | 0.465 | 0.470 | ||||||
No | 5 (62.5) | 3 (37.5) | Reference | 6 (75) | 2 (25) | Reference | ||
Yes | 6 (46.2) | 7 (53.8) | 1.58 (0.46-5.44) | 9 (69.2) | 4 (30.8) | 1.89 (0.34-10.61) | ||
Missing | 23 | 15 | 27 | 11 | ||||
Tumour site, n (%) | ||||||||
Right colon | 11 (68.7) | 5 (31.3) | Reference | 13 (81.3) | 3 (18.7) | Reference | ||
Left colon | 11 (42.3) | 15 (57.7) | 2.48 (0.89-6.88) | 0.081 | 20 (76.9) | 6 (23.1) | 1.73 (0.42-7.04) | 0.445 |
Rectum | 11 (68.7) | 5 (31.3) | 0.98 (0.28-3.41) | 0.972 | 9 (56.3) | 7 (43.7) | 2.34 (0.59-9.32) | 0.226 |
- Citation: Melli F, Bartolini I, Risaliti M, Tucci R, Ringressi MN, Muiesan P, Taddei A, Amedei A. Evaluation of prognostic factors and clinicopathological patterns of recurrence after curative surgery for colorectal cancer. World J Gastrointest Surg 2021; 13(1): 50-75
- URL: https://www.wjgnet.com/1948-9366/full/v13/i1/50.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i1.50